Risk factors for oxacillin/methicillin resistance in coagulase-negative staphylococci

Journal of Hospital Infection

Volumn 35, Issue 4, 1997, Pages 295-299

  Martinez J A ^a   Mensa, J ^a   Marco, F ^a   Almela, M ^a   Lopez, J ^a   Casals, C ^a   Soriano, E ^a   Jimenez De Anta M T ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Coagulase negative staphylococci; Methicillin resistance; Oxacillin resistance

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; METICILLIN; OXACILLIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RISK FACTOR;

EID: 0030920375     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90223-1     Document Type: Article

References (15)

1. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29 (Suppl. A): 19-24.
2. Eykyn SJ. Staphylococcal sepsis. The changing pattern of disease and therapy. Lancet 1988; i: 100-104.
3. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immunol 1982; 37: 318-326.
4. Goldmann DA. Coagulase-negative staphylococci: interplay of epidemiology and bench research. Am J Infect Control 1990; 18: 211-221.
5. Dunne WM, Mason EO, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37: 2522-2526.
6. Trilla A, Krueger WAK, Wenzel RP. Coagulase-negative staphylococcal sepsis: new problems, few solutions. J Crit Illness 1991; 6: 314-330.
7. Archer GL. Staphylococcus epidermidis: the organism, its diseases, and treatment. In: Remington JS, Swartz MN, Eds. Current Clinical Topics in Infectious diseases. New York: McGraw-Hill Book Company, 1986: 25-48.
8. Mouton RP, Simmons-Smit AM, Hoogkamp-Korstanje JAA, Degener JE, van Klingeren B. Correlation between consumption of antibiotics and methicillin resistance in coagulase-negative staphylococci. J Antimicrob Chemother 1990; 26: 573-583.
9. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281-299.
10. Hedin G, Hambraeus A. Multiply antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment - a one-week survey in a bone marrow transplant unit. J Hosp Infect 1991; 17: 95-106.
11. Thurn JR, Crossley KB, Gerdts A, Baken L. Dynamics of coagulase-negative staphylococcal colonization in patients and employees in a surgical intensive care unit. J Hosp Infect 1992; 20: 247-255.
12. McCabe WR, Jackson GC. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110: 845-855.
13. National Committee for Clinical Laboratory Standards. 1990. Performance Standards for Antimicrobial Disk Susceptibility test. M2-A4, 4th edn. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac patients receiving antibiotic prophylaxis. J Infect Dis 1983; 147: 642-649.
15. Archer GI. Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Mandell GL, Bennett JE, Dolin R, Eds. Principles and Practice of Infectious Diseases. 4th edn. New York: Churchill Livingstone, 1994: 1777-1784.